Diamant Asset Management Inc. Has $963,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Diamant Asset Management Inc. lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,257 shares of the company’s stock after acquiring an additional 410 shares during the quarter. Diamant Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $963,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of GEHC. LGT Financial Advisors LLC increased its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares during the last quarter. Fred Alger Management LLC acquired a new position in GE HealthCare Technologies during the second quarter worth approximately $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC bought a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $26,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in shares of GE HealthCare Technologies during the second quarter worth approximately $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.5 %

Shares of GEHC opened at $82.75 on Thursday. The company has a market capitalization of $37.81 billion, a PE ratio of 22.73, a PEG ratio of 2.91 and a beta of 1.08. GE HealthCare Technologies Inc. has a 12 month low of $71.24 and a 12 month high of $94.55. The stock’s 50-day moving average price is $86.21 and its two-hundred day moving average price is $83.71. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same period in the previous year, the business earned $0.99 EPS. The business’s quarterly revenue was up .9% compared to the same quarter last year. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is presently 3.85%.

Analyst Ratings Changes

GEHC has been the subject of several recent research reports. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Wednesday, September 18th. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Stifel Nicolaus raised their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.46.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.